| Sep 5 |
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
|
| Sep 4 |
NVS or LLY: Which Is the Better Value Stock Right Now?
|
| Sep 4 |
Novartis expands U.S. radiopharma production amid rising competition
|
| Sep 4 |
Novartis builds out radiopharma production with expansion, new factory
|
| Sep 4 |
Is Novartis AG (NVS) the Best Cancer Stock to Buy Now?
|
| Sep 3 |
Novartis (NVS) Upgraded to Buy: Here's What You Should Know
|
| Aug 31 |
ESC 2024: Study highlights potential for Novartis to differentiate in HF space
|
| Aug 29 |
Novartis teams up with Lindy Biosciences to improve biologic delivery
|
| Aug 29 |
Novartis' Cholesterol Drug Meets Primary Goals in Late-Stage Study
|
| Aug 29 |
Novartis’ Phase III trial of Leqvio in ASCVD patients meets primary endpoints
|
